More than 600 generic drugs have been added to TrumpRx, to help Americans find the best prices for their medications. President Donald Trump announced earlier this week that…
Read MoreMedication
HHS Takes Action to Curb Psychiatric Overprescribing
Secretary Kennedy shared information and resources and advocated for a reduction in prescription medications for mental health. The Department for Health and Human Services (HHS) announced plans to…
Read More
DOJ and DEA Announce Marijuana Rescheduling Actions
Certain medical marijuana products moved to Schedule III as broader review begins. The Justice Department (DOJ) and Drug Enforcement Administration (DEA) announced that FDA-approved products containing marijuana—along with…
Read More
NIH Study Reveals Effectiveness of Coordinated Care
The trial in community health centers showed reduced blood pressure in clinics. A clinical trial funded by the National Institutes of Health (NIH) found that a team-based treatment…
Read More
President Trump Orders FDA to Expedite Psychedelic Drug Reviews
Ibogaine compounds have been studied as potential therapies for treating mental health. President Donald Trump ordered the Food and Drug Administration to expedite and prioritize reviews of research…
Read More
U.S. Airlifts Medical Supplies to Venezuela
Shipment supports interim health authorities amid stabilization effort. President Trump’s administration directed an airlift of more than 6,000 kilograms of medical supplies to Venezuela as part of a…
Read More
Transportation Department Expands Drone Testing Locations
FAA designates new sites to support unmanned aircraft integration. The Department of Transportation (DOT) and the Federal Aviation Administration (FAA) announced two new Unmanned Aircraft Systems (UAS) test…
Read More
HHS and DEA Extend Telemedicine Prescribing Flexibilities Through 2026
Temporary extension maintains access to certain controlled medications. The Department of Health and Human Services (HHS), in coordination with the Drug Enforcement Administration (DEA), announced a fourth temporary…
Read More
FDA Approves Gene Therapy for Treating Spinal Muscular Atrophy
Patients of all ages now have access to care for the rare genetic disease. The Food and Drug Administration (FDA) has announced approval for Itvisma (onasemnogene abeparvovec-brve), which…
Read More
FDA Adds Warning and Restrictions to Duchenne Gene Therapy
Updated labeling limits treatment to ambulatory children after reports of fatal liver failure in non-ambulatory patients. The U.S. Food and Drug Administration (FDA) has approved significant labeling changes…
Read More